Polynucleotides (PDRN) in Microneedling with Growth Factors Protocols
Polynucleotides (PDRN) plays a key role in professional microneedling with growth factors treatments. DNA fragments derived from salmon or trout sperm that activate salvage pathway purine metabolism, stimulating fibroblast proliferation and tissue regeneration.
Role of Polynucleotides (PDRN) in Microneedling with Growth Factors
Controlled micro-injuries with derma pen devices combined with topical growth factors to stimulate natural collagen and elastin remodelling Polynucleotides (PDRN) enhances this treatment through its bio-revitalisation properties, providing regenerative support during and after the procedure.
Protocol Integration
In a typical microneedling with growth factors protocol, polynucleotides (pdrn) can be utilised at several stages:
- Pre-treatment: Skin preparation with polynucleotides (pdrn)-containing products to optimise treatment outcomes
- During treatment: Active polynucleotides (pdrn) delivery through the treatment modality for enhanced penetration
- Post-treatment: Recovery support using polynucleotides (pdrn) formulations to accelerate healing
Clinical Benefits
Combining polynucleotides (pdrn) with microneedling with growth factors offers several advantages:
- Enhanced bio-revitalisation through professional delivery methods
- Improved treatment outcomes with medical-grade regenerative support
- Reduced downtime and faster recovery when supported by polynucleotides (pdrn)
Skymedic Products
Skymedic offers professional-grade polynucleotides (pdrn) formulations specifically designed for integration with microneedling with growth factors protocols. All products manufactured under ISO 13485 standards.